“ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS”. 2012. Mediterranean Journal of Hematology and Infectious Diseases 4 (1): e2012072. https://doi.org/10.4084/mjhid.2012.072.